Life360, Inc. has disclosed a series of stock sales conducted by its director, John Coghlan, as outlined in a recent SEC filing. This activity is significant as it showcases the company's ongoing management of equity and may impact investor sentiment.

In the filing dated November 4, 2026, Coghlan sold a total of 4,000 shares of common stock on November 2, 2026. The sales were executed under a Rule 10b5-1 trading plan, which allows for pre-arranged stock transactions. The shares were sold at various prices, with the reported weighted average prices ranging from approximately $44.52 to $46.75.

Background

Life360, Inc. is a prominent player in the computer processing and data preparation industry, classified under SIC 7374. The company operates on the Nasdaq and OTC exchanges, with ticker symbols LIF and LIFX. As a large accelerated filer, Life360 is subject to rigorous reporting requirements and is committed to transparency in its financial dealings.

What the Filing Says

The SEC filing reveals that Coghlan sold 1,841 shares at $45.29, 1,433 shares at $46, and 726 shares at $46.69. Following these transactions, Coghlan retains a total of 10,590 shares directly owned and additional shares held in trusts.

Impact

This update may affect various stakeholders, including current and potential investors, who may interpret these transactions as signals of management's confidence in the company's future. The sales were conducted under a trading plan established in December 2025, indicating a structured approach to managing stock holdings.

What's Next

The filing does not say what happens next.